{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T04:15:45Z","timestamp":1783484145421,"version":"3.55.0"},"reference-count":58,"publisher":"Elsevier BV","issue":"1-2","license":[{"start":{"date-parts":[[2006,3,1]],"date-time":"2006-03-01T00:00:00Z","timestamp":1141171200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Molecular and Cellular Endocrinology"],"published-print":{"date-parts":[[2006,3]]},"DOI":"10.1016\/j.mce.2005.10.028","type":"journal-article","created":{"date-parts":[[2005,12,16]],"date-time":"2005-12-16T12:13:23Z","timestamp":1134735203000},"page":"34-40","source":"Crossref","is-referenced-by-count":37,"title":["Multiple endocrine neoplasia type 2 and the RET protooncogene: From bedside to bench to bedside"],"prefix":"10.1016","volume":"247","author":[{"given":"Andreas","family":"Machens","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henning","family":"Dralle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.mce.2005.10.028_bib1","doi-asserted-by":"crossref","first-page":"3121","DOI":"10.1038\/sj.onc.1203648","article-title":"Multiple endocrine neoplasia type 2B mutation in human RET oncogene induces medullary thyroid carcinoma in transgenic mice","volume":"19","author":"Acton","year":"2000","journal-title":"Oncogene"},{"key":"10.1016\/j.mce.2005.10.028_bib2","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1055\/s-2000-5806","article-title":"A RET double mutation in the germline of a kindred with FMTC","volume":"108","author":"Bartsch","year":"2000","journal-title":"Exp. Clin. Endocrinol. Diabetes"},{"key":"10.1016\/j.mce.2005.10.028_bib3","first-page":"7048","article-title":"Sporadic and familial pheochromocytomas are associated with loss of at least two discrete intervals on chromosome 1p","volume":"60","author":"Benn","year":"2000","journal-title":"Cancer Res."},{"key":"10.1016\/j.mce.2005.10.028_bib4","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1210\/jc.83.3.770","article-title":"A new hot spot for mutations in the ret protooncogene causing familial medullary thyroid carcinoma and multiple endocrine neoplasia type 2A","volume":"83","author":"Berndt","year":"1998","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.mce.2005.10.028_bib5","first-page":"2415","article-title":"RET mutations in exons 13 and 14 of FMTC patients","volume":"10","author":"Bolino","year":"1995","journal-title":"Oncogene"},{"key":"10.1016\/j.mce.2005.10.028_bib6","doi-asserted-by":"crossref","first-page":"5658","DOI":"10.1210\/jc.86.12.5658","article-title":"Consensus guidelines for diagnosis and therapy of MEN type 1 and type 2","volume":"86","author":"Brandi","year":"2001","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.mce.2005.10.028_bib7","first-page":"1077","article-title":"The kinase inhibitor PP1 blocks tumorigenesis induced by RET oncogenes","volume":"62","author":"Carlomagno","year":"2002","journal-title":"Cancer Res."},{"key":"10.1016\/j.mce.2005.10.028_bib8","first-page":"7284","article-title":"ZD6474, an orally available inhibitor of KDR tyrosine kinase activity, efficiently blocks oncogenic RET kinases","volume":"62","author":"Carlomagno","year":"2002","journal-title":"Cancer Res."},{"key":"10.1016\/j.mce.2005.10.028_bib9","doi-asserted-by":"crossref","first-page":"1897","DOI":"10.1210\/jc.2002-021278","article-title":"Efficient inhibition of RET\/papillary thyroid carcinoma oncogenic kinases by 4-amino-5-(4-chloro-phenyl)-7-(t-butyl)pyrazolo[3,4-d]pyrimidine (PP2)","volume":"88","author":"Carlomagno","year":"2003","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.mce.2005.10.028_bib10","doi-asserted-by":"crossref","first-page":"6056","DOI":"10.1038\/sj.onc.1207810","article-title":"Disease associated mutations at valin 804 in the RET receptor tyrosine kinase confer resistance to selective kinase inhibitors","volume":"23","author":"Carlomagno","year":"2004","journal-title":"Oncogene"},{"key":"10.1016\/j.mce.2005.10.028_bib11","doi-asserted-by":"crossref","first-page":"2851","DOI":"10.1038\/sj.onc.1202202","article-title":"Dual effect on the RET receptor of MEN-2 mutations affecting specific extracytoplasmic cysteines","volume":"17","author":"Chappuis-Flament","year":"1998","journal-title":"Oncogene"},{"key":"10.1016\/j.mce.2005.10.028_bib12","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1002\/1096-9896(2000)9999:9999<::AID-PATH679>3.0.CO;2-B","article-title":"Clonal patterns in phaeochromocytomas and MEN-2A adrenal medullary hyperplasias: histological and kinetic correlates","volume":"192","author":"Diaz-Cano","year":"2000","journal-title":"J. Pathol."},{"key":"10.1016\/j.mce.2005.10.028_bib13","doi-asserted-by":"crossref","first-page":"3948","DOI":"10.1210\/jc.86.8.3948","article-title":"Germline RET 634 mutation positive MEN-2A related C-cell hyperplasias have genetic features consistent with intraepithelial neoplasia","volume":"86","author":"Diaz-Cano","year":"2001","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.mce.2005.10.028_bib14","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1093\/hmg\/2.7.851","article-title":"Mutations of the RET protooncogene are associated with MEN-2A and FMTC","volume":"2","author":"Donis-Keller","year":"1993","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.mce.2005.10.028_bib15","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1007\/978-3-642-84749-3_9","article-title":"Surgical management of MEN-2","volume":"125","author":"Dralle","year":"1992","journal-title":"Recent Results Cancer Res."},{"key":"10.1016\/j.mce.2005.10.028_bib16","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1007\/s002689900463","article-title":"Prophylactic thyroidectomy in 75 children and adolescents with hereditary medullary thyroid carcinoma: German and Austrian experience","volume":"22","author":"Dralle","year":"1998","journal-title":"World J. Surg."},{"key":"10.1016\/j.mce.2005.10.028_bib17","doi-asserted-by":"crossref","first-page":"5823","DOI":"10.1210\/jc.2004-0312","article-title":"Identification of a novel point mutation in the RET gene (Ala883Thr), which is associated with medullary thyroid carcinoma phenotype only in homozygous condition","volume":"89","author":"Elisei","year":"2004","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.mce.2005.10.028_bib18","first-page":"509","article-title":"A novel point mutation in the tyrosine kinase domain of the RET protooncogene in sporadic medullary thyroid carcinoma and in a family with FMTC","volume":"10","author":"Eng","year":"1995","journal-title":"Oncogene"},{"key":"10.1016\/j.mce.2005.10.028_bib19","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1001\/jama.276.19.1575","article-title":"The relationship between specific RET protooncogene mutations and disease phenotype in multiple endocrine neoplasia type 2","volume":"276","author":"Eng","year":"1996","journal-title":"J. Am. Med. Assoc."},{"issue":"Suppl. 1","key":"10.1016\/j.mce.2005.10.028_bib20","doi-asserted-by":"crossref","first-page":"S167","DOI":"10.1002\/humu.1380110156","article-title":"A GTG to ATG novel point mutation at codon 804 in exon 14 of the RET proto-oncogene in two families affected by familial thyroid carcinoma","author":"Fattoruso","year":"1998","journal-title":"Hum. Mutat."},{"key":"10.1016\/j.mce.2005.10.028_bib21","doi-asserted-by":"crossref","first-page":"1780","DOI":"10.1210\/jc.81.5.1780","article-title":"Mutations of the ret protooncogene in German multiple endocrine neoplasia families: relation between genotype and phenotype","volume":"81","author":"Frank-Raue","year":"1996","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.mce.2005.10.028_bib22","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1038\/367375a0","article-title":"A mutation in the RET protooncogene associated with multiple endocrine neoplasia type 2B and sporadic medullary thyroid carcinoma","volume":"367","author":"Hofstra","year":"1994","journal-title":"Nature"},{"key":"10.1016\/j.mce.2005.10.028_bib23","doi-asserted-by":"crossref","first-page":"4176","DOI":"10.1210\/jc.82.12.4176","article-title":"A novel point mutation in the intracellular domain of the ret protooncogene in a family with medullary thyroid carcinoma","volume":"82","author":"Hofstra","year":"1997","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.mce.2005.10.028_bib24","first-page":"6223","article-title":"Duplication of the mutant RET allele in trisomy 10 or loss of the wild-type allele in multiple endocrine neoplasia type 2-associated pheochromocytomas","volume":"60","author":"Huang","year":"2000","journal-title":"Cancer Res."},{"key":"10.1016\/j.mce.2005.10.028_bib25","first-page":"2870","article-title":"Biological properties of RET with cysteine mutations correlate with multiple endocrine neoplasia type 2A, familial medullary thyroid carcinoma, and Hirschsprung's disease phenotype","volume":"57","author":"Ito","year":"1997","journal-title":"Cancer Res."},{"key":"10.1016\/j.mce.2005.10.028_bib26","doi-asserted-by":"crossref","first-page":"3919","DOI":"10.1038\/sj.onc.1202742","article-title":"Biological and biochemical properties of RET with kinase domain mutations identified in multiple endocrine neoplasia type 2B and familial medullary thyroid carcinoma","volume":"18","author":"Iwashita","year":"1999","journal-title":"Oncogene"},{"key":"10.1016\/j.mce.2005.10.028_bib27","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1006\/bbrc.2000.2227","article-title":"A two-hit model for development of multiple endocrine neoplasia type 2B by RET mutations","volume":"268","author":"Iwashita","year":"2000","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.mce.2005.10.028_bib28","doi-asserted-by":"crossref","first-page":"3907","DOI":"10.1158\/0008-5472.CAN-03-3801","article-title":"Expression profiles provide insights into early malignant potential and skeletal abnormalities in multiple endocrine neoplasia type 2B syndrome tumors","volume":"64","author":"Jain","year":"2004","journal-title":"Cancer Res."},{"key":"10.1016\/j.mce.2005.10.028_bib29","first-page":"5254","article-title":"Tissue-specific carcinogenesis in transgenic mice expressing the RET protooncogene with a multiple endocrine neoplasia type 2A mutation","volume":"60","author":"Kawai","year":"2000","journal-title":"Cancer Res."},{"key":"10.1016\/j.mce.2005.10.028_bib30","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1038\/sj.onc.1205133","article-title":"Somatic VHL gene deletion and point mutation in MEN-2A-associated pheochromocytoma","volume":"21","author":"Koch","year":"2002","journal-title":"Oncogene"},{"key":"10.1016\/j.mce.2005.10.028_bib31","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1002\/1097-0142(19950801)76:3<479::AID-CNCR2820760319>3.0.CO;2-M","article-title":"Analysis of RET protooncogene point mutations distinguishes heritable from nonheritable medullary thyroid carcinomas","volume":"76","author":"Komminoth","year":"1995","journal-title":"Cancer"},{"key":"10.1016\/j.mce.2005.10.028_bib32","doi-asserted-by":"crossref","first-page":"3454","DOI":"10.1210\/jc.2004-1622","article-title":"Germline homozygous mutations at codon 804 in the RET protooncogene in medullary thyroid carcinoma\/multiple endocrine neoplasia type 2A patients","volume":"90","author":"Lesueur","year":"2005","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.mce.2005.10.028_bib33","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1056\/NEJM199409293311302","article-title":"Clinical screening as compared with DNA analysis in families with multiple endocrine neoplasia type 2A","volume":"331","author":"Lips","year":"1994","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.mce.2005.10.028_bib34","doi-asserted-by":"crossref","first-page":"4383","DOI":"10.1210\/jc.2004-2526","article-title":"Adrenal ganglioneuromas in children with multiple endocrine neoplasia type 2: a report of two cases","volume":"90","author":"Lora","year":"2005","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.mce.2005.10.028_bib35","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1210\/jc.86.3.1104","article-title":"Genotype\u2013phenotype correlations in hereditary medullary thyroid carcinoma: oncological features and biochemical properties","volume":"86","author":"Machens","year":"2001","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.mce.2005.10.028_bib36","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1007\/s00268-001-0176-3","article-title":"Pattern of nodal metastasis for primary and reoperative thyroid cancer","volume":"26","author":"Machens","year":"2002","journal-title":"World J. Surg."},{"key":"10.1016\/j.mce.2005.10.028_bib37","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1067\/S0039-6060(03)00157-0","article-title":"Malignant progression from C-cell hyperplasia to medullary thyroid carcinoma in 167 carriers of RET germline mutations","volume":"134","author":"Machens","year":"2003","journal-title":"Surgery"},{"key":"10.1016\/j.mce.2005.10.028_bib38","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1056\/NEJMoa012915","article-title":"Early malignant progression of hereditary medullary thyroid cancer","volume":"349","author":"Machens","year":"2003","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.mce.2005.10.028_bib39","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1016\/j.surg.2004.04.034","article-title":"Emergence of medullary thyroid carcinoma in a family with the Cys630Arg RET germline mutation","volume":"136","author":"Machens","year":"2004","journal-title":"Surgery"},{"key":"10.1016\/j.mce.2005.10.028_bib40","doi-asserted-by":"crossref","first-page":"3999","DOI":"10.1210\/jc.2005-0064","article-title":"Codon-specific development of pheochromocytoma in multiple endocrine neoplasia type 2","volume":"90","author":"Machens","year":"2005","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.mce.2005.10.028_bib41","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1111\/j.1365-2796.2004.01423.x","article-title":"Advances in the management of hereditary thyroid cancer","volume":"257","author":"Machens","year":"2005","journal-title":"J. Intern. Med."},{"key":"10.1016\/j.mce.2005.10.028_bib42","doi-asserted-by":"crossref","unstructured":"Machens, A., Dralle, H., in press. DNA-based window of opportunity for curative pre-emptive therapy of hereditary medullary thyroid cancer. Surgery.","DOI":"10.1016\/j.surg.2005.07.034"},{"key":"10.1016\/j.mce.2005.10.028_bib43","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1158\/0008-5472.CAN-04-2363","article-title":"RET-familial medullary thyroid carcinoma mutants Y971F and S891A activate a Src\/JAK\/STAT3 pathway, independent of glial cell line-derived neurotrophic factor","volume":"65","author":"Menacho","year":"2005","journal-title":"Cancer Res."},{"key":"10.1016\/j.mce.2005.10.028_bib44","doi-asserted-by":"crossref","first-page":"3330","DOI":"10.1073\/pnas.94.7.3330","article-title":"Development of medullary thyroid carcinoma in transgenic mice expressing the RET protooncogene altered by a multiple endocrine neoplasia type 2A mutation","volume":"94","author":"Michiels","year":"1997","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.mce.2005.10.028_bib45","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1038\/363458a0","article-title":"Germline mutations of the RET protooncogene in multiple endocrine neoplasia type 2A","volume":"363","author":"Mulligan","year":"1993","journal-title":"Nature"},{"key":"10.1016\/j.mce.2005.10.028_bib46","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1038\/ng0194-70","article-title":"Specific mutations of the RET proto-oncogene are related to disease phenotype in MEN-2A and FMTC","volume":"6","author":"Mulligan","year":"1994","journal-title":"Nat. Genet."},{"key":"10.1016\/j.mce.2005.10.028_bib47","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1111\/j.1365-2796.1995.tb01208.x","article-title":"Genotype\u2013phenotype correlation in multiple endocrine neoplasia type 2: report of the International RET mutation consortium","volume":"238","author":"Mulligan","year":"1995","journal-title":"J. Intern. Med."},{"key":"10.1016\/j.mce.2005.10.028_bib48","first-page":"1814","article-title":"Polymorphisms G691S\/S904S of RET as genetic modifiers of MEN-2A","volume":"63","author":"Robledo","year":"2003","journal-title":"Cancer Res."},{"key":"10.1016\/j.mce.2005.10.028_bib49","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1126\/science.7824936","article-title":"Activation of RET as a dominant transforming gene by germline mutations of MEN2A and MEN2B","volume":"267","author":"Santoro","year":"1995","journal-title":"Science"},{"key":"10.1016\/j.mce.2005.10.028_bib50","first-page":"233","article-title":"Prevalence and parental origin of de novo RET mutations in multiple endocrine neoplasia type 2A and familial medullary thyroid carcinoma","volume":"60","author":"Schuffenecker","year":"1995","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.mce.2005.10.028_bib51","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1210\/jc.83.2.487","article-title":"Risk and penetrance of primary hyperparathyroidism in multiple endocrine neoplasia type 2A families with mutations at codon 634 of the RET protooncogene","volume":"83","author":"Schuffenecker","year":"1998","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.mce.2005.10.028_bib52","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1056\/NEJMoa043999","article-title":"Prophylactic thyroidectomy in multiple endocrine neoplasia type 2A","volume":"353","author":"Skinner","year":"2005","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.mce.2005.10.028_bib53","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1093\/emboj\/19.4.612","article-title":"C-cell hyperplasia, pheochromocytoma, and sympathoadrenal malformation in a mouse model of multiple endocrine neoplasia type 2B","volume":"19","author":"Smith-Hick","year":"2000","journal-title":"EMBO J."},{"key":"10.1016\/j.mce.2005.10.028_bib54","first-page":"5559","article-title":"CEP-701 and CEP-751 inhibit constitutively activated RET tyrosine kinase activity and block medullary thyroid carcinoma cell growth","volume":"63","author":"Strock","year":"2003","journal-title":"Cancer Res."},{"key":"10.1016\/j.mce.2005.10.028_bib55","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/0092-8674(85)90115-1","article-title":"Activation of a novel human transforming gene, ret, by DNA rearrangement","volume":"42","author":"Takahashi","year":"1985","journal-title":"Cell"},{"key":"10.1016\/j.mce.2005.10.028_bib56","doi-asserted-by":"crossref","first-page":"3522","DOI":"10.1210\/jc.84.10.3522","article-title":"A novel case of multiple endocrine neoplasia type 2A associated with two de novo mutations of the RET protooncogene","volume":"84","author":"Tessitore","year":"1999","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.mce.2005.10.028_bib57","first-page":"4645","article-title":"ZD6474 inhibits vascular endothelial growth factor signaling, angiogenesis, and tumor growth following oral administration","volume":"62","author":"Wedge","year":"2002","journal-title":"Cancer Res."},{"key":"10.1016\/j.mce.2005.10.028_bib58","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1097\/00000658-199409000-00002","article-title":"Predictive DNA testing and prophylactic thyroidectomy in patients at risk for multiple endocrine neoplasia type 2A","volume":"220","author":"Wells","year":"1994","journal-title":"Ann. Surg."}],"container-title":["Molecular and Cellular Endocrinology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0303720705004028?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0303720705004028?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,4,11]],"date-time":"2019-04-11T07:06:24Z","timestamp":1554966384000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0303720705004028"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,3]]},"references-count":58,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2006,3]]}},"alternative-id":["S0303720705004028"],"URL":"https:\/\/doi.org\/10.1016\/j.mce.2005.10.028","relation":{},"ISSN":["0303-7207"],"issn-type":[{"value":"0303-7207","type":"print"}],"subject":[],"published":{"date-parts":[[2006,3]]}}}